Nucleate Announces MilliporeSigma as a New Platinum Sponsor of the 2023 Activator Program
Nucleate, a nonprofit organization dedicated to empowering future biotech leaders, is delighted to announce that MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, will be a Platinum sponsor of Nucleate’s 2023 Activator program.
Nucleate’s equity-free Activator program has supported early-stage development of more than 100 venture teams including Glyphic, NextRNA, and Manifold Bio. The 2023 Activator program commenced this January and will support over 140 new ventures worldwide. Activator teams will participate in hands-on workshops and receive mentorship from industry experts throughout the program, culminating in a final pitch showcase.
MilliporeSigma proudly champions the continuous efforts aimed at improving the quality of life. As a Platinum level sponsor, MilliporeSigma will support future scientific leaders who are navigating cutting-edge technologies and discoveries. MilliporeSigma will provide financial resources, enable access to scientific expertise, and on an annual basis, celebrate accomplishments with a High Impact Award which captures the essence of positive change through innovation and collaboration.
“We are thrilled to be collaborating with MilliporeSigma to equip our community of rising life science leaders and entrepreneurs with industry-leading resources,” said Zach Cogan, Nucleate EVP of Partnerships. “MilliporeSigma’s dedication to supporting the life science entrepreneurship ecosystem strongly aligns with our mission, and this partnership will enable critical support for emerging life science innovators.”
“The launch of our Nucleate sponsorship reinforces our commitment to advancing scientific breakthroughs. We are excited to support the efforts of next generation scientists and fuel their discoveries which will strengthen the drug discovery pipeline and ultimately improve healthcare,” said Heather Ahlborn, SVP, Commercial Americas MilliporeSigma.
MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. As part of a vibrant science and technology company with over 350 years of history, the unique MilliporeSigma® brands include Sigma-Aldrich®, Millipore®, Milli-Q®, Supelco®, BioReliance®, Millipore CTDMO® and SAFC®. With a strong commitment to improve the quality of life, its broad portfolio provides researchers access to innovative products, services, and digital offerings.
Nucleate is a nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 23 geographic regions and participation from over 120 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information.
About the Activator Program
Nucleate’s flagship educational program, Activator, facilitates the formation of new life science companies solving pressing biomedical or ecological challenges. Unlike traditional accelerators, Activator is an equity-free, fee-free, hands-on entrepreneurship program that stimulates regional innovation and builds a global community of biotech entrepreneurs. The program empowers academic trainees to translate their groundbreaking science into successful companies, Activator facilitates entrepreneurial education through team formation, mentorship and expert support, rigorous workshop series, and a final pitch showcase.